z-logo
open-access-imgOpen Access
Dual effect of 2-methoxyestradiol on cell cycle events in human osteosarcoma 143B cells.
Author(s) -
Justyna Gołębiewska,
Piotr Rozwadowski,
Jan Henryk Spodnik,
Narcyz Knap,
Takashi Wakabayashi,
Michał Woźniak
Publication year - 2002
Publication title -
acta biochimica polonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.452
H-Index - 78
eISSN - 1734-154X
pISSN - 0001-527X
DOI - 10.18388/abp.2002_3821
Subject(s) - 2 methoxyestradiol , cell cycle , osteosarcoma , metabolite , cell cycle checkpoint , cell growth , apoptosis , chemistry , cell , cell culture , microbiology and biotechnology , cell division , in vivo , estrogen , cancer research , biology , biochemistry , endocrinology , genetics
We have demonstrated for the first time that the steroid metabolite, 2-methoxyestradiol (2-ME) is a powerful growth inhibitor of human osteosarcoma 143 B cell line by pleiotropic mechanisms involving cell cycle arrest at two different points and apoptosis. The ability of 2-ME to inhibit cell cycle at the respective points has been found concentration dependent. 1 microM 2-ME inhibited cell cycle at G1 phase while 10 microM 2-ME caused G2/M cell cycle arrest. As a natural estrogen metabolite 2-ME is expected to perturb the stability of microtubules (MT) in vivo analogously to Taxol--the MT binding anticancer agent. Contrary to 2-ME, Taxol induced accumulation of osteosarcoma cells in G2/M phase of cell cycle only. The presented data strongly suggest two different mechanisms of cytotoxic action of 2-ME at the level of a single cell.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom